15 news items
HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $15 Price Target
IVVD
14 May 24
HC Wainwright & Co. analyst Patrick Trucchio reiterates Invivyd (NASDAQ:IVVD) with a Buy and maintains $15 price target.
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
IVVD
7 May 24
targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein have been highly effective therapeutic options for symptomatic COVID-19
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDAâ„¢
IVVD
15 Apr 24
in target population WALTHAM, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc
Invivyd Announces CEO Transition
IVVD
12 Apr 24
according to estimates from the Centers for Disease Control and Prevention. PEMGARDA targets the SARS-CoV-2 spike protein receptor binding domain (RBD
Guggenheim Upgrades Invivyd to Buy, Announces $9 Price Target
IVVD
5 Apr 24
Guggenheim analyst Evan Wang upgrades Invivyd (NASDAQ:IVVD) from Neutral to Buy and announces $9 price target.
xe963k1 j3nio
CNK
CRBU
DNUT
5 Apr 24
Neutral to Overweight and raised its price target from $14 to $20.
Forge Global Holdings, Inc
sd91qtx67rro71 gwrfemnk0psvsl8ytlysp35eozwze82s0f
IVVD
4 Apr 24
according to estimates from the Centers for Disease Control and Prevention. PEMGARDA targets the SARS-CoV-2 spike protein receptor binding domain (RBD
eyoujx1r ev5w
AHG
AKBA
APCX
26 Mar 24
to Overweight and raised the price target from $4 to $10.
Sunnova Energy International Inc
jmurdhxe4nulhdoejg0p5azf3h
APPF
CGC
DNUT
26 Mar 24
to Overweight and raised its price target from $4 to $10.
Qurate Retail Inc
z3vfx35v1lo77cf1bvueph7x5 vhhxfzg
APCX
BREA
BZFD
26 Mar 24
. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10
zms3olhol1bwy2vy9mgb0v8mbxok3f
IVVD
26 Mar 24
Morgan Stanley analyst Maxwell Skor upgrades Invivyd (NASDAQ:IVVD) from Equal-Weight to Overweight and raises the price target from $4 to $10.
yz6gws002uwnu9pmkwn4syz1v1hgpjofhwvg8tx7pml1rbxzyib
ABBV
AEHR
AKAN
25 Mar 24
offering.
Target Hospitality Corp. (NASDAQ:TH) jumped 21.3
004z0rdatn
IVVD
25 Mar 24
HC Wainwright & Co. analyst Patrick Trucchio reiterates Invivyd (NASDAQ:IVVD) with a Buy and maintains $15 price target.
ylph5toi781gtxmy0dhobgbew42mwlg5q3b41
IVVD
22 Mar 24
targeting conserved epitopes that could be deployed to keep pace with SARS-CoV-2 viral evolution or other viral threats. With a commitment to serial
dzrsrp8jnw19sxnkfuzrtjou7mdakgzu80jorifn149cyiyopsyrh2
IVVD
22 Mar 24
is designed to enable the rapid, serial generation of durable mAbs targeting conserved epitopes that could be deployed to keep pace with SARS-CoV-2 viral
- Prev
- 1
- Next